These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4946490)

  • 1. [Effects of 1-adamantil-amine chlorhydrate on parkinsonian asynkinesia].
    Megna G
    Acta Neurol (Napoli); 1971; 26(6):701-6. PubMed ID: 4946490
    [No Abstract]   [Full Text] [Related]  

  • 2. The therapeutic possibilities of L-dopa and amantadine in Parkinsonian patients who have undergone bilateral thalamotomy.
    Giuffrè R; Gambacorta D
    Eur Neurol; 1971; 5(5):311-6. PubMed ID: 4943872
    [No Abstract]   [Full Text] [Related]  

  • 3. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes].
    Kluzer G; Lampo B
    Minerva Med; 1971 Oct; 62(82):4013-4. PubMed ID: 5125067
    [No Abstract]   [Full Text] [Related]  

  • 4. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes and their implications for rehabilitation].
    Raspa EG; Paciaroni E; Saccomanno G
    Minerva Med; 1971 Oct; 62(82):4031-5. PubMed ID: 5125073
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physiopathology and symptomatology of parkinsonian movement disorders in the light of recent therapeutic progress].
    Ferrari E
    Sist Nerv; 1970; 22(2):164-74. PubMed ID: 4926919
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electrophysiological findings during treatment of the parkinsonian syndrome with amantadine].
    Di Perri R; Livrea P; Messina C; Puca FM; Tomasello F
    Minerva Med; 1971 Oct; 62(82):3997-9. PubMed ID: 4331007
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
    Ambrosetto C; Martinelli P
    Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
    Ciuca I; Bulandra R; Serbanesco A; Ninosu N
    Rev Neurol (Paris); 1972 Aug; 127(2):305-8. PubMed ID: 4672049
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on parkinsonian asynkinesia before and after stereotaxic intervention].
    Oratino A; Tanga U
    Boll Soc Ital Biol Sper; 1964 Jan; 40(2):58-60. PubMed ID: 5337388
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary results of the use of amantadine in parkinsonian syndromes].
    Montanari M; Monaco V; Robotti CA
    Minerva Med; 1971 Oct; 62(82):3955-7. PubMed ID: 5125050
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary psychological findings during treatment of the parkinsonian syndrome with amantadine. Preliminary observations].
    Barbieri NF; Megna GF; Micalizzi V; Pigneri MT; Puca FM
    Minerva Med; 1971 Oct; 62(82):4000-3. PubMed ID: 5125063
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of parkinsonian states with L-dopa].
    Boudin G; Guillard A; Pépin B
    Bull Acad Natl Med; 1971 Nov; 155(28):707-12. PubMed ID: 4948142
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects induced by the treatment with amantadine on habituation of trigemino-facial reflexes in Parkinsonian patients].
    Messina C; Tomasello F
    Riv Neurol; 1972; 42(2):202-8. PubMed ID: 4341955
    [No Abstract]   [Full Text] [Related]  

  • 14. [Psychologic evaluation of amantadine treatment of parkinsonism and comparative analysis of the effects with L-dopa].
    Puca FM; Micalizzi V; Megna GF; Barbieri NF; Pigneri MT
    Acta Neurol (Napoli); 1971; 26(6):707-30. PubMed ID: 4946491
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of a previous thalamotomy on the L-dopa effects on mono-manual dexterity in parkinsonism.
    Knutsson E; Mårtensson A; Meyerson BA; Risberg AM
    Scand J Rehabil Med; 1973; 5(3):130-3. PubMed ID: 4754551
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical evaluation of amantadine therapy for parkinsonism and the side effects--in cases of thalamic surgery and L-dopa therapy.
    Matsumoto K; Omoto T; Beck H
    Folia Psychiatr Neurol Jpn; 1974 Jan; 28(1):1-10. PubMed ID: 4406943
    [No Abstract]   [Full Text] [Related]  

  • 17. The management of Parkinson's syndrome.
    Wanger SL
    Med Clin North Am; 1972 May; 56(3):693-709. PubMed ID: 4556201
    [No Abstract]   [Full Text] [Related]  

  • 18. L-dopa and amantadine for Parkinsonism.
    Drug Ther Bull; 1970 Aug; 8(17):65-7. PubMed ID: 5480244
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic association of amantadine and L-Dopa in parkinsonism].
    Signorelli CD; D'Andrea F; De Divitiis E; Cerillo A
    Minerva Med; 1971 Oct; 62(82):4015-6. PubMed ID: 5125068
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prolonged treatment of Parkinson's disease with amantadine and L-Dopa].
    Fieschi C; Casacchia M; Nardini M; Reitano N
    Minerva Med; 1971 Oct; 62(82):4040-2. PubMed ID: 5125075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.